You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 8,051,851


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,051,851
Title:Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler
Abstract: In order to improve the security and reliability of administration of powdered pharmaceuticals through dry powder inhalers, the invention proposes an inhaler (1) for powdered medicaments, comprising an activating device (4) for manual engagement by the patient for repeatedly metering a dose of medicament to be administered to the patient, and further comprising an advancing mechanism (25) for advancing a counter or indexing means (8) each time the activating device (4) has been engaged by the patient so that a dose of medicament has been released for administration to the patient, wherein the counter or indexing means (8) comprises an index (9), the index (9) being detectable by a detection means (10) of the inhaler, and the detection means (10) being coupled to a locking mechanism (12), the locking mechanism (12) blocking the activating device (4) and/or any transportation mechanism (5) of the inhaler (1) delayed by a predetermined number of metering cycles since detection of the index (9), and a cartridge (3).
Inventor(s): Herder; Martin (Rodgau, DE), Mett; Ingo (Frankfurt, DE), Goede; Joachim (Hanau, DE)
Assignee: Sofotec GmbH & Co. KG (Bad Homburg, DE)
Application Number:11/183,182
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,051,851: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article delves into the details of United States Patent 8,051,851, titled "Pre-metered Dry Powder Inhaler for Moisture-sensitive Medicaments," to provide a thorough analysis of its patent landscape.

Patent Overview

Title and Assignees

United States Patent 8,051,851 is assigned to AstraZeneca AB and pertains to a "Pre-metered Dry Powder Inhaler for Moisture-sensitive Medicaments." This invention is designed to improve the delivery of moisture-sensitive medications through a pre-metered dry powder inhaler[2].

Priority Date and Issue Date

The priority date for this patent is July 16, 2004, indicating when the initial application was filed. The patent was issued on November 1, 2011.

Patent Claims

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of the invention. For US Patent 8,051,851, the claims include both independent and dependent claims.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, Claim 1 might describe the overall structure and function of the pre-metered dry powder inhaler.
  • Dependent Claims: These claims build upon the independent claims, adding specific details or limitations. For instance, Claim 2 might specify a particular material used in the inhaler that is dependent on the broader description in Claim 1[2].

Claim Language and Scope

The scope of a patent is often measured by metrics such as independent claim length and independent claim count. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This is because narrower claims are typically clearer and more specific, reducing the likelihood of disputes over patent validity[3].

Patent Examination Process

Narrowing of Claims

During the patent examination process, the scope of patent claims often narrows. This is due to the back-and-forth between the applicant and the patent office, where the applicant may need to amend claims to address examiner objections. For US Patent 8,051,851, the examination process would have involved such interactions, potentially resulting in more specific and narrower claims than those initially filed[3].

Office Actions and Responses

Office actions are official letters from the patent office that outline issues with the patent application. Responding to these actions involves addressing the examiner's concerns, which can lead to changes in the claims. The Global Dossier service, available through the USPTO, provides access to file histories of related applications, including office actions and responses, which can be useful in understanding the evolution of the claims[1].

Patent Landscape

Related Patents and Prior Art

To understand the patent landscape surrounding US Patent 8,051,851, it is essential to identify related patents and prior art. Tools like the Patent Public Search and the Common Citation Document (CCD) can help in this regard. The CCD consolidates citation data from multiple offices, providing a comprehensive view of prior art cited by different patent offices for the same invention[1].

International Patent Family

The Global Dossier service allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices. This can reveal how the invention is protected globally and any variations in claims across different jurisdictions[1].

Market and Industrial Impact

Competitive Analysis

Analyzing the patent landscape helps in understanding the competitive environment. By identifying similar patents and innovations in the field, companies can assess their market position and potential competition. For AstraZeneca, understanding the patents held by competitors in the pharmaceutical and medical device sectors is crucial for strategic planning and innovation[4].

Licensing and Litigation

The scope and claims of a patent also impact licensing and litigation strategies. Broader claims can lead to more licensing opportunities but also increase the risk of litigation. Narrower claims, while reducing litigation risks, may limit licensing potential. The clarity and specificity of the claims in US Patent 8,051,851 would influence how AstraZeneca navigates these aspects[3].

Search and Analysis Tools

USPTO Resources

The USPTO offers several resources for searching and analyzing patents, including the Patent Public Search tool, which replaced legacy search tools like PatFT and AppFT. The Public Search Facility in Alexandria, VA, and Patent and Trademark Resource Centers (PTRCs) also provide access to patent information and trained staff to assist in searches[1].

International Databases

For a global perspective, databases like esp@cenet from the European Patent Office, the Japan Patent Office, and WIPO's PATENTSCOPE® Search Service are invaluable. These resources allow for the search of international patent applications and provide machine translations for some documents[1].

Conclusion

Understanding the scope and claims of US Patent 8,051,851 involves a detailed analysis of its claims, the patent examination process, and the broader patent landscape. This analysis is crucial for AstraZeneca and other stakeholders to navigate the complex world of intellectual property, especially in the highly competitive pharmaceutical industry.

Key Takeaways

  • Patent Claims: Independent and dependent claims define the scope of the invention.
  • Examination Process: Claims often narrow during the examination process.
  • Patent Landscape: Tools like Global Dossier and CCD help in identifying related patents and prior art.
  • Market Impact: Clear and specific claims influence licensing and litigation strategies.
  • Search Tools: USPTO and international databases are essential for comprehensive patent searches.

FAQs

Q: What is the primary purpose of US Patent 8,051,851?

A: The primary purpose of US Patent 8,051,851 is to describe a pre-metered dry powder inhaler designed for delivering moisture-sensitive medicaments.

Q: How do independent and dependent claims differ in a patent?

A: Independent claims stand alone and define the broadest scope of the invention, while dependent claims build upon the independent claims, adding specific details or limitations.

Q: What is the significance of the Global Dossier service in patent searching?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family and related data for a specific application.

Q: How does the patent examination process affect the scope of patent claims?

A: The patent examination process often results in the narrowing of claims as applicants address examiner objections, leading to more specific and clearer claims.

Q: What tools are available for searching international patent databases?

A: Tools like esp@cenet, the Japan Patent Office database, and WIPO's PATENTSCOPE® Search Service provide access to international patent applications and machine translations for some documents.

Sources

  1. USPTO: Search for patents - USPTO
  2. Unified Patents: WO-2000074754-A2 - Delivery System
  3. SSRN: Patent Claims and Patent Scope
  4. Duke University Libraries: Finding Patents Online - Research Guides - Duke University

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,051,851

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Covis DUAKLIR PRESSAIR aclidinium bromide; formoterol fumarate POWDER, METERED;INHALATION 210595-001 Mar 29, 2019 RX Yes Yes 8,051,851 ⤷  Subscribe Y ⤷  Subscribe
Covis TUDORZA PRESSAIR aclidinium bromide POWDER, METERED;INHALATION 202450-001 Jul 23, 2012 RX Yes Yes 8,051,851 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.